Jeff LaConte

Vice President - Global Marketing and Business Development at MMI

Jeff LaConte has a diverse work experience spanning various industries. Jeff currently serves as the Vice President of Global Marketing and Business Development at Medical Microinstruments, Inc., where they are involved in pushing the boundaries of microsurgery and improving the quality of patient care. Before that, they held leadership roles at DePuy Synthes, including Vice President of WW Robotics & Augmented Reality Surgical Solutions and Lead of Digital Surgery and Robotics.

Jeff also worked at Johnson & Johnson Vision, where they served as the General Manager of Ocular Surface and led the commercial integration of acquired companies into the Johnson & Johnson Surgical Vision organization. Additionally, they were the Senior Director of Global Brand Management for Johnson & Johnson Vision Care, where they oversaw the marketing strategy for various contact lens brands.

Earlier in their career, LaConte worked at Ethicon, Inc. as the Director of U.S. Brand Marketing and Product Director of Marketing. In these roles, they were responsible for driving revenue and market share goals for surgical device portfolios and managing direct-to-consumer marketing efforts for the REALIZE brand.

LaConte also has experience in sales and marketing at Procter & Gamble, where they managed a pharmacologic portfolio, and at NASCAR, where they served as a Marketing Manager and handled marketing plans and sponsor relationships.

Overall, Jeff LaConte has demonstrated a strong track record of leadership and strategic decision-making in the healthcare, medical devices, and consumer goods industries.

Jeff LaConte received their Bachelor of Science (BS) degree in Business from Florida State University, which they attended from 1996 to 2000. Later, they pursued a Master of Business Administration (MBA) degree from Saint Leo University from 2004 to 2007.

Links

Org chart

Timeline

  • Vice President - Global Marketing and Business Development

    March, 2023 - present

View in org chart